v3.26.1
Condensed Consolidated Interim Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities    
Net loss $ (16,812,249) $ (10,211,551)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 100,778 95,171
Gain on sale of property and equipment (11,629)  
Stock-based compensation expense 1,539,939 1,364,633
Changes in current assets and liabilities:    
Prepaid expenses and other current assets (313,892) (69,156)
Accounts payable and accrued liabilities (9,405) 235,387
Net cash used in operating activities (15,506,458) (8,585,516)
Investing activities    
Purchases and advances for property and equipment (708,933)  
Proceeds from the sale of property and equipment 13,000  
Purchases of mineral rights and properties (750,030) (20,000)
Net cash used in investing activities (1,445,963) (20,000)
Financing activities    
Proceeds from exercise of stock options 748,293 96,000
Proceeds from exercise of warrants 10,898,838 1,856,608
Payments of income taxes on performance stock units ("PSUs"), restricted stock units ("RSUs") and shares issued for compensation (283,573) (785,458)
Principal repayment on finance lease liability (493)  
Net cash provided by financing activities 86,562,011 41,168,261
Net change in cash and cash equivalents 69,609,590 32,562,745
Cash and cash equivalents, beginning of period 29,686,451 9,408,270
Cash and cash equivalents, end of period 99,296,041 41,971,015
Non-cash investing and financing activities and supplemental cash flow information    
Amortization and expiration of deferred ATM Program costs offset against additional paid-in capital (25,727) (37,293)
Addition of right-of-use asset classified as finance lease in exchange for lease liability 988,422  
Interest paid on finance lease liability 9,507  
Common stock issued for accrued bonuses   113,958
ATM Program    
Financing activities    
Proceeds from sale of common stock, net of issuance costs 3,487,919 7,316,230
Public offering    
Financing activities    
Proceeds from sale of common stock, net of issuance costs $ 71,711,027 $ 32,684,881